{"nct_id":"NCT03665597","title":"Relative Bioavailability Study of Subcutaneous Injection Versus Intravenous Infusion of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-555/KEYNOTE-555)","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2018-11-19","start_date_type":"ACTUAL","primary_completion_date":"2023-12-04","primary_completion_date_type":"ACTUAL","completion_date":"2023-12-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}